joint pain glp-1 Glucagon-like peptide-1 receptor agonists in arthritis: current insights and future directions Do glucagon-like peptide‑1 (GLP‑1) receptor

For most patients over 40 with mixed goals (fat loss, anti-aging, and recovery), CJC-1295/Ipamorelin is the most commonly recommended starting protocol because of its broad effects across the systems most affected by age-related GH decline

Oxidative stress responses clarified the functioning of central principal switches like nuclear factor (NF)-B (NFB) or the Kelch-like ECH-associated protein 1 (Keap1)-Nuclear factor erythroid 2-related factor2 (Nrf2)-antioxidant response element (ARE) redox regulator pathway (Sies, 2015

Further research is needed to examine these processes (164)

Those treated with an SGLT2i were more than twice as likely to develop a UTI or pyelonephritis than those treated with a GLP-1 RA (RR 2.27 [95% CI 1.12, 4.55] p =0.019)

In other words: this isnt a blanket ban on GLP1 APIs